Back

EMPEROR - Empagliflozin in Patients with Chronic Heart Failure

25 August 2023 (08:30 - 08:45)
Organised by: Logo
Congress Presentation Part of: Clinical trial updates on heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Milton Packer

Baylor University Medical Center, Dallas (United States of America)

5 More presentations in this session

Presentation thumbnail
Renal Outcomes in PARAGLIDE-HF and PARAGON-HF
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Effects of Dapagliflozin in Patients with Heart Failure and Deterioration of Kidney Function Below eGFR 25ml/min/1.73m^2
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
STRONG-HF
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
OPT-PACE - Optimising therapy in patients with pacemakers
Doctor K. Witte (Leeds, GB)
Slides Video
Presentation thumbnail
The ADVOR trial: update on renal interactions
Doctor J. Dauw (Aalst, BE)
Slides Video

Access the full session

Session thumbnail
Clinical trial updates on heart failure
Video

The Event

Event poster

ESC Congress 2023

25 August 2023 08:30 CET
You may be interested in
thumbnail
Congress Presentation
What is the evidence for empagliflozin in HF?
22 May 2022
thumbnail
Congress Presentation
Short- and long-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure
30 August 2025
thumbnail
Congress Presentation
Prognostic implications of angiopoietin-2 in heart failure and the influence of empagliflozin: the EMPEROR program
28 August 2023
thumbnail
Congress Presentation
Discussant review - FINEARTS-HF
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources